The effect of elranatamab against multiple myeloma cells is mediated by CD8+ cells
Takaaki Takeda(Fujisawa City Hospital), Hideaki Nakajima(Yokohama City University Hospital), Kota Kawabata(Museum of Japanese Art Yamato Bunkakan), Yuki Nakajima(Fujisawa City Hospital), Ayako Bouno(Fujisawa City Hospital), Katsumichi Fujimaki(Fujisawa City Hospital)
Cited by 1
Related Papers
Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside
|Journal of Medicinal Chemistry|1991|85
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era
|European Journal Of Haematology|2013|58
Heat stress results in incomplete C-to-U editing of maize chloroplast mRNAs and correlates with changes in chloroplast transcription rate
|Current Genetics|2001|53
Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma.
|PubMed|1998|51
Determination of the Disulfide Array in Sapecin, an Antibacterial Peptide of Sarcophaga peregrina (Flesh Fly)1
|The Journal of Biochemistry|1990|48